JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2019 • Corriente Advisors, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2019 Company IndustryThe undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, par value $0.001 per share, of Catabasis Pharmaceuticals, Inc. dated as of February 13, 2019 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.